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The controversy over the operative indication in 
atherosclerotic disease of the carotid bifurcation is 
with us for nearly four decades. Previous studies 
showed fairly convincingly the usefulness of surgical 
treatment in symptomatic arotid disease but in 
patients whose carotid stenosis did not induce clinical 
symptoms, the question of appropriateness of carotid 
endarterectomy was left open. 
Despite the above, based on statistically unsup- 
ported logic and on surgical intuition, the lionshare of 
vascular surgeons continued to operate severe 
( > 70-80%) carotid stenoses, ymptomatic or not. This 
view was certainly not shared by the entire spectrum 
of our profession. In an unpublished survey we 
conducted 5 years ago among members of respective 
specialities, only two out of 10 neurologists, about five 
out of 10 neurosurgeons but eight out of 10 vascular 
surgeons were in favour for surgery in clinically 
asymptomatic but anatomically severe carotid bifurca- 
tion disease. The debate heated up considerably 
during the past few years when several attempts were 
made by different insurance companies to disqualify 
surgical services for asymptomatic carotid patients. 
In an apparent attempt to settle the matter for "once 
and for all," the National Institute of Neurological 
Disorder and Stroke, National Institutes of Health 
established the Asymptomatic Carotid Atherosclerosis 
Study (ACAS) headed by James F. Toole, Teagle 
Professor of Neurolog~ Bowman Gray School of 
Medicine. The charge of The Study Committee, which 
based its findings upon data collected in 18 institu- 
tions of large operative volume and of professional 
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excellence was to "determine whether the addition of 
carotid endarterectomy to aspirin plus risk factor 
modifications affect the incidence of ipsilateral tran- 
sient ischaemic attack, amaurosis fugax, and retinal 
and cerebral infarction in patients with asymptomatic 
haemodynamically significant carotid stenosis?" The 
study applied two validation programs; Doppler/ 
angiogram correlation and transient ischaemic attack/ 
stroke questionnaire. Secondary objectives were: (1) to 
determine surgical success rate, (2) to review the fate 
of the atherosclerotic plaque in the medically treated 
patients, and (3) to examine the rate of other cardiac 
and vascular events. By November, 1988, 145 patients 
with asymptomatic carotid stenosis ( > 60%) have been 
randomized between medical and surgical treatment 
and the goal was to randomize a total of 750 patients 
in each study group. To participate in the studN a 
surgeon must have performed an annual minimum of 
12 carotid endarterectomies with a morbidity/mortal- 
ity rate no greater than 3% in the last 50 cases. 
While ACAS expected to run for several additional 
years, on September 28, 1994 the National Institutes of 
Health issued an Advisory which recognised the 
superiority of carotid endarterectomy over conserva- 
tive management by the "reduction of 5.8% in the risk 
of the primary end point of stroke within 5 years and 
a relative risk reduction of 55%." The Advisory 
continued with the warning by the ACAS Data 
Monitoring Committee to all physicians participating 
in the study to immediately re-evaluate their patients 
included in the "medical management" leg of the 
project as potential candidates for surgical treatment. 
This Advisory effectively terminated the ACAS trial. 
While the detailed results of the ACAS study have 
not been released yet, one may indeed draw some 
conclusions: 
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The profession owes indeed gratitude to the partici- 
pants of the ACAS, particularly to the principal 
investigator, James Toole, not only for their bold 
approach which led to the long overdue solution of a 
very important clinical problem. On the other hang as 
may be not optimal from a "pure" scientific viewpoint, 
we do have to understand those, who convinced of the 
appropriateness of surgery in the "clinically asympto- 
matic but anatomically severe" subgroup, and were 
reluctant to participate in the ACAS project as not to 
jeopardise their patients by randomisation. 
Second, it has to be emphasised that the now 
terminated ACAS project puts the surgical indication 
in clinically asymptomatic but anatomically severe 
carotid disease on a firm scientific base, that this 
conclusion is based on the presumptive professional 
excellence, specially on the low operative morbidity 
and mortality of the operating surgeons. Unless we 
can match such standards identified, we are not 
justified to use the ACAS as the base of our treatment 
recommendations. 
Acknowledging the great merits of ACAS, we also 
intend to call attention to a shortcoming which should, 
however, not change the final conclusion. 
We believe that 60% non-complex stenosis used by 
the ACAS investigators as the trigger point of inclu- 
sion may not be a significant enough threat to the 
patients health, and that a more stringent end-point, 
like 70% narrowing would have been more proper. 
One may also speculate that such a 70% study entry- 
point would have further widened the difference in 
the outcome between the medically and the surgically 
treated groups, and would have even further emphas- 
ised the advantage of surgery. 
Considering all of the above, one should consider 
the following based on the ACAS study as recom- 
mendations for consideration for surgical intervention 
in occlusive xtracranial carotid artery disease: 
1. In absence of special contraindications, carotid 
arterial stenosis, if anatomically significant and 
clinically symptomatic, should be operated on. 
2. Patients with > 60% obstruction to the internal 
carotid flow should undergo carotid endarter- 
ectom~ even if they are asymptomatic, given 
experienced vascular surgical facilities with low 
morbidity and mortality rates. 
The author of this editorial, however, expresses 
some reservation on this 60% "trigger" value of 
asymptomatic obstruction and views a somewhat 
tighter stenosis, i.e. 70% more appropriate. In addition 
to the above, we also believe that: 
1. Patients with small ulcers in the carotid bifurca- 
tion suspected of causing transient ischaemic 
attacks may receive a trial of antiplatelet therapy 
(aspirin and/or Persantine), but should be oper- 
ated on if evidence suggests repeated embolisa- 
tion while on such medication. 
2. Presence of large, complex ulcers at the carotid 
bifurcation represent surgical indication per se. 
3. Patients with moderate (50-60%) carotid artery 
stenoses may be considered as candidates for 
surgery regardless of their asymptomatic or 
symptomatic state, if the contralateral internal 
carotid artery is completely occluded. 
4. We strongly recommend that patients with mod- 
erate (< 60%) asymptomatic carotid stenosis, and 
those who have no known carotid disease but 
who have evidence of severe arteriosclerosis in 
the other organs ystems, should undergo yearly 
non-invasive studies for carotid artery disease. 
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